Phibro Animal Health (PAHC) Share-based Compensation (2018 - 2026)
Phibro Animal Health's (PAHC) quarterly Share-based Compensation came in at $179000.0 in Q1 2026, little changed year-on-year from $179000.0 in Q1 2025, and down 0.56% quarter-over-quarter from $180000.0 in Q4 2025.
Phibro Animal Health (PAHC) Share-based Compensation (2018 - 2026) Analysis & Trends
Phibro Animal Health's Share-based Compensation history runs 7 years deep, the most recent figure standing at $179000.0 for Q1 2026.
- On a quarterly basis, Share-based Compensation changed 0.0% year-over-year to $179000.0 in Q1 2026; TTM through Mar 2026 was $877000.0, a 22.32% increase from a year earlier, with the FY2025 full-year figure at $717000.0, up 50.95% from the prior year.
- Share-based Compensation fell to $179000.0 in Q1 2026 per PAHC's latest filing, from $180000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $339000.0 in Q3 2025 and bottomed at $80000.0 in Q4 2023.
- The 4-year median for Share-based Compensation is $179000.0 (2024), against an average of $171818.2.
- Across the five-year window, Share-based Compensation surged 125.0% in 2024 and changed 0.0% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $80000.0 in 2023, then jumped by 125.0% to $180000.0 in 2024, then changed by 0.0% to $180000.0 in 2025, then fell by 0.56% to $179000.0 in 2026.
- Per Business Quant, the three latest PAHC Share-based Compensation figures stand at $179000.0 (Q1 2026), $180000.0 (Q4 2025), and $339000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 179,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179,000.00 |
| Mar 31, 2026 | 179,000.00 |
| Dec 31, 2025 | 180,000.00 |
| Dec 31, 2025 | 180,000.00 |
| Sep 30, 2025 | 339,000.00 |
| Sep 30, 2025 | 339,000.00 |
| Jun 30, 2025 | 179,000.00 |
| Jun 30, 2025 | 179,000.00 |
| Mar 31, 2025 | 179,000.00 |
| Mar 31, 2025 | 179,000.00 |
| Dec 31, 2024 | 180,000.00 |
| Dec 31, 2024 | 180,000.00 |
| Sep 30, 2024 | 179,000.00 |
| Sep 30, 2024 | 179,000.00 |
| Jun 30, 2024 | 179,000.00 |
| Jun 30, 2024 | 179,000.00 |
| Mar 31, 2024 | 135,000.00 |
| Mar 31, 2024 | 135,000.00 |
| Dec 31, 2023 | 80,000.00 |
| Dec 31, 2023 | 80,000.00 |